Indivior sticks to FY outlook, warns of hit from generic rival

British drugmaker Indivior Plc stuck to its full-year forecast on Wednesday even after a U.S. court allowed an Indian generic rival to sell a copycat version of Indvior's blockbuster opioid addiction treatment drug.

from Reuters: Money News https://ift.tt/2DAxctt
via IFTTT

• Tweet
• Share
• Share
• Share
• Share